Invention Grant
US09585956B2 Polynucleotides encoding anti-amyloid beta monoclonal antibodies
有权
编码抗淀粉样蛋白β单克隆抗体的多核苷酸
- Patent Title: Polynucleotides encoding anti-amyloid beta monoclonal antibodies
- Patent Title (中): 编码抗淀粉样蛋白β单克隆抗体的多核苷酸
-
Application No.: US14861001Application Date: 2015-09-22
-
Publication No.: US09585956B2Publication Date: 2017-03-07
- Inventor: Andrea Pfeifer , Maria Pihlgren , Andreas Muhs , Ryan Watts
- Applicant: AC IMMUNE S.A. , GENENTECH, INC.
- Applicant Address: CH Lausanne US CA South San Francisco
- Assignee: AC IMMUNE S.A.,GENENTECH, INC.
- Current Assignee: AC IMMUNE S.A.,GENENTECH, INC.
- Current Assignee Address: CH Lausanne US CA South San Francisco
- Agency: Jones Day
- Main IPC: C07H21/04
- IPC: C07H21/04 ; C07K16/18 ; A61K39/395 ; G01N33/68 ; A61K31/5513 ; A61K45/06 ; C07K16/44 ; C07K14/47 ; A61K39/00
Abstract:
The antibodies enabled by the teaching of the present invention are particularly useful for the treatment of diseases and disorders which are caused by or associated with amyloid or amyloid-like proteins including amyloidosis, a group of diseases and disorders associated with amyloid plaque formation including secondary amyloidosis and age-related amyloidosis including, but not limited to, neurological disorders such as Alzheimer's Disease (AD).
Public/Granted literature
- US20160000910A1 Monoclonal Antibody Public/Granted day:2016-01-07
Information query
